Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enzon Pharmaceuticals (ENZN)
:ENZN
Holding ENZN?
Track your performance easily
ENZN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.24
Previous CloseN/A
Volume3.72K
Average Volume (3M)107.67K
Market Cap
$11.87M
Enterprise ValueN/A
Total Cash (Recent Filing)$7.64M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)45.2
Beta0.30
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Sep 30, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding74,214,600
10 Day Avg. Volume60,742
30 Day Avg. Volume107,675
Standard Deviation0.27
R-Squared0.00278
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)427.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Enzon Pharmaceuticals News
PremiumCompany Announcements
Enzon Pharmaceuticals Expands Board and Forms Strategic CommitteeOwnership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ENZN FAQ
What was Enzon Pharmaceuticals’s price range in the past 12 months?
Enzon Pharmaceuticals lowest stock price was $0.06 and its highest was $0.24 in the past 12 months.
What is Enzon Pharmaceuticals’s market cap?
Enzon Pharmaceuticals’s market cap is $11.87M.
When is Enzon Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Enzon Pharmaceuticals’s earnings last quarter?
Enzon Pharmaceuticals released its earnings results on Aug 03, 2023. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
Is Enzon Pharmaceuticals overvalued?
According to Wall Street analysts Enzon Pharmaceuticals’s price is currently Overvalued.
Does Enzon Pharmaceuticals pay dividends?
Enzon Pharmaceuticals pays a Notavailable dividend of $0.119 which represents an annual dividend yield of N/A. See more information on Enzon Pharmaceuticals dividends here
What is Enzon Pharmaceuticals’s EPS estimate?
Enzon Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzon Pharmaceuticals have?
Enzon Pharmaceuticals has 74,214,600 shares outstanding.
What happened to Enzon Pharmaceuticals’s price movement after its last earnings report?
Enzon Pharmaceuticals reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Enzon Pharmaceuticals?
Currently, no hedge funds are holding shares in ENZN
---
Company Description
Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.
---
Technical Analysis
Avinger
―
Brainstorm Cell Therapeutics
―
CASI Pharmaceuticals
―
Cyclacel Pharmaceuticals
―
Crispr Therapeutics AG
―
Ionis Pharmaceuticals
―
---